Activist 13D/13G Filings - Kynam Capital Management LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-03-08
3:58 pm
Purchase
13GMorphoSys AG
MOR
Kynam Capital Management LP4,190,331
11.130%
500,000increase
(+13.55%)
View
2024-02-14
12:53 pm
Sale
13GOLEMA PHARMACEUTICALS INC
OLMA
Kynam Capital Management LP0
0.000%
-2,025,234decrease
(Position Closed)
View
2024-02-14
12:52 pm
Purchase
13GCELLDEX THERAPEUTICS INC C
CLDX
Kynam Capital Management LP3,005,904
5.500%
3,005,904increase
(New Position)
View
2024-02-14
12:51 pm
Purchase
13GCOGENT BIOSCIENCES INC
COGT
Kynam Capital Management LP5,854,766
6.800%
5,854,766increase
(New Position)
View
2024-02-14
12:50 pm
Purchase
13GSYNDAX PHARMACEUTICALS INC
SNDX
Kynam Capital Management LP5,660,000
6.670%
5,660,000increase
(New Position)
View
2024-02-14
12:49 pm
Purchase
13GVera Therapeutics Inc.
VERA
Kynam Capital Management LP3,650,339
8.220%
2,241,241increase
(+159.06%)
View
2024-02-14
12:47 pm
Purchase
13GMorphoSys AG
MOR
Kynam Capital Management LP3,690,331
9.800%
3,690,331increase
(New Position)
View
2024-02-14
12:45 pm
Unchanged
13GBURNING ROCK BIOTECH LTD SPONS
BNR
Kynam Capital Management LP8,694,426
10.190%
0
(Unchanged)
View
2024-01-10
4:08 pm
Purchase
13GBURNING ROCK BIOTECH LTD SPONS
BNR
Kynam Capital Management LP8,694,426
10.190%
1,302,845increase
(+17.63%)
View
2023-09-06
4:54 pm
Purchase
13G2SEVENTY BIO INC
TSVT
Kynam Capital Management LP5,953,825
11.700%
5,953,825increase
(New Position)
View
2023-03-21
5:40 pm
Sale
13GOLEMA PHARMACEUTICALS INC
OLMA
Kynam Capital Management LP2,025,234
5.000%
-38,398,598decrease
(-94.99%)
View
2023-02-13
09:25 am
Unchanged
13GCONCERT PHARMACEUTICALS INC.
CNCE
Kynam Capital Management LP4,420,349
9.200%
0
(Unchanged)
View
2023-02-10
3:51 pm
Purchase
13GCONCERT PHARMACEUTICALS INC.
CNCE
Kynam Capital Management LP4,420,349
9.200%
4,420,349increase
(New Position)
View
2023-02-10
1:20 pm
Purchase
13GVera Therapeutics Inc.
VERA
Kynam Capital Management LP1,409,098
5.100%
1,409,098increase
(New Position)
View
2023-02-10
1:18 pm
Purchase
13GOLEMA PHARMACEUTICALS INC
OLMA
Kynam Capital Management LP40,423,832
5.000%
40,423,832increase
(New Position)
View
2023-02-10
1:16 pm
Purchase
13GBURNING ROCK BIOTECH LTD SPONS
BNR
Kynam Capital Management LP7,391,581
8.400%
7,391,581increase
(New Position)
View